In delivered nanomedicine crossing the BBB continuously makes highly active bche

Ended Project Grant Awarded Last action

Award ID
HDTRA11310049
Recipient
Awarding agency
Obligated
$5,083,968

Award facts

Assistance listing
12.351 Scientific Research - Combating Weapons of Mass Destruction
Completion date
Originally
Place of performance
Potomac, MD 20854, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $101,184
Amendment $100,000
Amendment $150,900
Amendment $180,000
Amendment $102,055
Amendment $219,093
Amendment $90,000
Amendment $99,998
Amendment $805,211
Amendment $580,113
Amendment $80,000
Amendment $251,106
Amendment $200,000
Amendment $148,615
Amendment $209,654
Amendment In delivered nanomedicine crossing the BB continiously makes highly active cbhe $605,813
Amendment $580,113
Original award In delivered nanomedicine crossing the BBB continuosly makes highly active bche. $580,113
Show all 18

Quick answers

Who received award HDTRA11310049?

HDTRA11310049 was awarded to Synergene Therapeutics Inc. by Defense Threat Reduction Agency (Department of Defense) on September 20, 2013.

How much is award HDTRA11310049 worth?

$5,083,968 has been obligated on HDTRA11310049.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award